Figure 5
From: Development of a ferroptosis-based molecular markers for predicting RFS in prostate cancer patients
A survival analysis of high and low risk groups in training cohorts (A) and (B), testing cohorts (C) and (D), the entire TCGA cohort (E) and (F), and validating cohorts (G) and (H) was conducted, and the area beneath the ROC curve was also examined for all of them.
